HR Execs on the Move

Ardea Biosciences

www.ardeabio.com

 
Ardea Biosciences is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.ardeabio.com
  • 4939 Directors Pl
    San Diego, CA USA 92121
  • Phone: 858.652.6500

Executives

Name Title Contact Details

Similar Companies

Solvay Pharmaceuticals Inc

Solvay Pharmaceuticals Inc is a Marietta, GA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Sandia Springs Assisted Living

Sandia Springs Assisted Living is a Rio Rancho, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

All American Health Care Services

All American Health Care Services is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lynnhurst Healthcare Ctr

Arkansas-based Beverly (NYSE: BEV) operates 351 nursing homes, 18 assisted living centers and 52 hospice and home health centers.

scPharmaceuticals

scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.